Omics and Drug Response

被引：106
作者：
Meyer, Urs A. [1 ]
Zanger, Ulrich M. [2 ]
Schwab, Matthias [2 ,3 ]
机构：
[1] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[3] Univ Tubingen Hosp, Dept Clin Pharmacol, D-72076 Tubingen, Germany
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 | 2013年 / 53卷
关键词：
genomic medicine; personalized medicine; pharmacogenetics; pharmacogenomics; biomarkers; genotype-phenotype; GENOME-WIDE ASSOCIATION; IMPLEMENTATION CONSORTIUM GUIDELINES; ACUTE LYMPHOBLASTIC-LEUKEMIA; SYSTEMS BIOLOGY APPROACH; BREAST-CANCER PATIENTS; COLORECTAL-CANCER; HYPERSENSITIVITY REACTIONS; MISSING HERITABILITY; CLINICAL DEVELOPMENT; GENETIC-VARIATION;
D O I：
10.1146/annurev-pharmtox-010510-100502
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A new generation of technologies commonly named omics permits assessment of the entirety of the components of biological systems and produces an explosion of data and a major shift in our concepts of disease. These technologies will likely shape the future of health care. One aspect of these advances is that the data generated document the uniqueness of each human being in regard to disease risk and treatment response. These developments have reemphasized the concept of personalized medicine. Here we review the impact of omics technologies on one key aspect of personalized medicine: the individual drug response. We describe how knowledge of different omics may affect treatment decisions, namely drug choice and drug dose, and how it can be used to improve clinical outcomes.
引用
收藏
页码：475 / 502
页数：28
相关论文
共 198 条
  • [21] Emergency Hospitalizations for Adverse Drug Events in Older Americans
    Budnitz, Daniel S.
    Lovegrove, Maribeth C.
    Shehab, Nadine
    Richards, Chesley L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21) : 2002 - 2012
  • [22] Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
    Chen, Pei
    Lin, Juei-Jueng
    Lu, Chin-Song
    Ong, Cheung-Ter
    Hsieh, Peiyuan F.
    Yang, Chih-Chao
    Tai, Chih-Ta
    Wu, Shey-Lin
    Lu, Cheng-Hsien
    Hsu, Yung-Chu
    Yu, Hsiang-Yu
    Ro, Long-Sun
    Lu, Chung-Ta
    Chu, Chun-Che
    Tsai, Jing-Jane
    Su, Yu-Hsiang
    Lan, Sheng-Hsing
    Sung, Sheng-Feng
    Lin, Shu-Yi
    Chuang, Hui-Ping
    Huang, Li-Chen
    Chen, Ying-Ju
    Tsai, Pei-Joung
    Liao, Hung-Ting
    Lin, Yu-Hsuan
    Chen, Chien-Hsiun
    Chung, Wen-Hung
    Hung, Shuen-Iu
    Wu, Jer-Yuarn
    Chang, Chi-Feng
    Chen, Luke
    Chen, Yuan-Tsong
    Shen, Chen-Yang
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12) : 1126 - 1133
  • [23] Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
    Chen, Rui
    Mias, George I.
    Li-Pook-Than, Jennifer
    Jiang, Lihua
    Lam, Hugo Y. K.
    Chen, Rong
    Miriami, Elana
    Karczewski, Konrad J.
    Hariharan, Manoj
    Dewey, Frederick E.
    Cheng, Yong
    Clark, Michael J.
    Im, Hogune
    Habegger, Lukas
    Balasubramanian, Suganthi
    O'Huallachain, Maeve
    Dudley, Joel T.
    Hillenmeyer, Sara
    Haraksingh, Rajini
    Sharon, Donald
    Euskirchen, Ghia
    Lacroute, Phil
    Bettinger, Keith
    Boyle, Alan P.
    Kasowski, Maya
    Grubert, Fabian
    Seki, Scott
    Garcia, Marco
    Whirl-Carrillo, Michelle
    Gallardo, Mercedes
    Blasco, Maria A.
    Greenberg, Peter L.
    Snyder, Phyllis
    Klein, Teri E.
    Altman, Russ B.
    Butte, Atul J.
    Ashley, Euan A.
    Gerstein, Mark
    Nadeau, Kari C.
    Tang, Hua
    Snyder, Michael
    [J]. CELL, 2012, 148 (06) : 1293 - 1307
  • [24] Comprehensive genomic characterization defines human glioblastoma genes and core pathways
    Chin, L.
    Meyerson, M.
    Aldape, K.
    Bigner, D.
    Mikkelsen, T.
    VandenBerg, S.
    Kahn, A.
    Penny, R.
    Ferguson, M. L.
    Gerhard, D. S.
    Getz, G.
    Brennan, C.
    Taylor, B. S.
    Winckler, W.
    Park, P.
    Ladanyi, M.
    Hoadley, K. A.
    Verhaak, R. G. W.
    Hayes, D. N.
    Spellman, Paul T.
    Absher, D.
    Weir, B. A.
    Ding, L.
    Wheeler, D.
    Lawrence, M. S.
    Cibulskis, K.
    Mardis, E.
    Zhang, Jinghui
    Wilson, R. K.
    Donehower, L.
    Wheeler, D. A.
    Purdom, E.
    Wallis, J.
    Laird, P. W.
    Herman, J. G.
    Schuebel, K. E.
    Weisenberger, D. J.
    Baylin, S. B.
    Schultz, N.
    Yao, Jun
    Wiedemeyer, R.
    Weinstein, J.
    Sander, C.
    Gibbs, R. A.
    Gray, J.
    Kucherlapati, R.
    Lander, E. S.
    Myers, R. M.
    Perou, C. M.
    McLendon, Roger
    [J]. NATURE, 2008, 455 (7216) : 1061 - 1068
  • [25] Using metabolomics to monitor anticancer drugs
    Chung, Y. -L.
    Griffiths, J. R.
    [J]. ONCOGENES MEET METABOLISM: FROM DEREGULATED GENES TO A BROADER UNDERSTANDING OF TUMOUR PHYSIOLOGY, 2008, 4 : 55 - 78
  • [26] Pharmaco-metabonomic phenotyping and personalized drug treatment
    Clayton, TA
    Lindon, JC
    Cloarec, O
    Antti, H
    Charuel, C
    Hanton, G
    Provost, JP
    Le Net, JL
    Baker, D
    Walley, RJ
    Everett, JR
    Nicholson, JK
    [J]. NATURE, 2006, 440 (7087) : 1073 - 1077
  • [27] Finishing the euchromatic sequence of the human genome
    Collins, FS
    Lander, ES
    Rogers, J
    Waterston, RH
    [J]. NATURE, 2004, 431 (7011) : 931 - 945
  • [28] A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
    Cooper, Gregory M.
    Johnson, Julie A.
    Langaee, Taimour Y.
    Feng, Hua
    Stanaway, Ian B.
    Schwarz, Ute I.
    Ritchie, Marylyn D.
    Stein, C. Michael
    Roden, Dan M.
    Smith, Joshua D.
    Veenstra, David L.
    Rettie, Allan E.
    Rieder, Mark J.
    [J]. BLOOD, 2008, 112 (04) : 1022 - 1027
  • [29] Gastrointestinal stromal tumours: origin and molecular oncology
    Corless, Christopher L.
    Barnett, Christine M.
    Heinrich, Michael C.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (12) : 865 - 878
  • [30] Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology
    Cox, Juergen
    Mann, Matthias
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80, 2011, 80 : 273 - 299
12345678910